Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study using cultured human cells (no clinical human data).
PubMed 20049504 · doi:10.1007/s00018-009-0242-9
What was done
Researchers examined the mechanisms of replicative senescence in cultured human multipotent stem cells (MSCs). They analyzed changes in the expression of histone deacetylases (HDACs), Polycomb group (PcG) genes (BMI1, EZH2, SUZ12), and jumonji domain containing 3 (JMJD3). They also evaluated the effects of HDAC inhibitors, retinoblastoma protein (RB) phosphorylation and E2F transcriptional activity, promoter histone acetylation of JMJD3, and the protective effect of a histone acetyltransferase (HAT) inhibitor.
What was found
The abstract reports no numerical values or effect sizes. Senescent MSCs exhibited decreased HDAC expression, downregulated PcG genes (BMI1, EZH2, SUZ12), and upregulated JMJD3. Chemical HDAC inhibition induced senescence through RB hypophosphorylation (reducing E2F transcriptional activity) and promoter acetylation-dependent upregulation of JMJD3. Treatment with a HAT inhibitor prevented MSC replicative senescence.
Why it matters
This study delineates an epigenetic regulatory circuit where HDAC activity delays adult stem cell senescence by balancing PcG-mediated repression and JMJD3-driven activation of p16(INK4A).
Limits
The study is restricted to in vitro human cell culture models without in vivo validation. The abstract omits sample size, donor demographics, quantification of gene expression changes, and statistical significance metrics.
Cited by
- supports The p16INK4a gene is methylated during early life and undergoes progressive demethylation as an individual ages.